The EU drugs agency (EMCDDA) launches today three new resources looking at drug overdoses in Europe and the interventions in place to prevent them
Bibliography: Interventions – Prevention
Road to Recovery (PDF)
Addiction in our society – the case for reform (Centre for Social Justice)
Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm (Public Health England)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017. The number of treated cases increased from 8,361 in 2011 to 9,892 in 2015, and then decreased to 8,922 in 2017
National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018
On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
Drug prevention: exploring a systems perspective
This report considers substance use prevention in Europe through the lens of a system, highlighting the wide range of factors that need to be addressed to successfully implement substance use prevention programmes and policies (EMCDDA)
Facial recognition technology to help in fight against prison drug trafficking
Justice Secretary announces successful trial of new biometric technology (Ministry of Justice)
UNODC/WHO International Standards on Drug Use Prevention Second updated edition
This second updated edition of the Standards and has been published jointly with the World Health Organisation. As in the case of the first edition, the Standards summarize the currently available scientific evidence, describing interventions and policies that have been found to result in positive prevention outcomes and their characteristics
Rights, Respect and Recovery (PDF)
Scotland’s strategy to improve health by preventing and reducing alcohol and drug use, harm and related deaths (Scottish Government)
Preventing overdose deaths in Europe (Perspectives on drugs)
More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate Download (EMCDDA)
Key Findings from RAND Health’s Research on Opioid Policy
This policy brief highlights key findings from RAND research on opioid-related issues across a spectrum of policy areas including prevention, treatment, quality of care, and supply (RAND)
Public health guidance on prevention and control of blood-borne viruses in prison settings
This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region (EMCDDA)
Cannabis and driving: questions and answers for policymaking
With cannabis use and policy evolving internationally, drug-impaired driving has become an increasingly relevant policy issue. This briefing aims to provide those concerned with policy developments in the field of cannabis with a brief overview of current knowledge and the latest developments in the area of drivinG (EMCDDA)
Mutual aid toolkit for alcohol and drug misuse treatment
Evidence and guidance on the benefits of mutual aid in preventing and treating alcohol and drug dependency (Public Health England)
Drug misuse prevention
This quality standard covers the prevention or delay of harmful use of drugs by children, young people and adults most likely to start using drugs, or already experimenting or using drugs occasionally (NICE)
Hepatitis C in England 2018 report (PDF)
In this report, we summarise the impact of action plans in England to drive down mortality from HCV, reduce the number of new infections, and outline the actions required to make further progress (Public Health England)
Drug testing in schools
This paper evaluates the effectiveness of random testing in schools, based on studies conducted among students aged 13 to 19 years, in the United States. Although different with regard to study design and the type of testing offered, all of the studies show that testing has little or no effect on drug use (EMCDDA)
NIDA launches two adolescent substance use screening tools
These tools can be self-administered or completed by clinicians in less than two minutes. They are being offered through the NIDAMED Web Portal
Ending the opioid crisis: a practical guide for state policymakers
This guide shows state policymakers how to implement a public health approach to end the opioid epidemic (CASA)
Women who use drugs: Issues, needs, responses, challenges and implications for policy and practice (PDF)
Background paper commissioned by the EMCDDA for
Health and social responses to drug problems: a European guide
